Leerink Partners LLC

Leerink Partners LLC, based in the US, operates as a specialized healthcare investment bank, providing expert financial advisory services exclusively for the healthcare sector. Founded in 1995 in Boston, US, Leerink Partners LLC specializes in healthcare investment banking. The firm has undergone no major pivots in its business strategy. It was founded by Eric Swann, who has a background in the investment banking industry.

Leerink has successfully completed two deals, with the most recent deal occurring on April 1, 2013. The firm's latest funding round was a Growth round, raising USD 35. 00 mn from investors including Lovell Minnick Partners and March Group, bringing the total amount raised to USD 35. 00 mn.

Leerink Partners primarily operates as a specialized healthcare investment bank, providing a range of financial advisory services tailored exclusively for the healthcare sector. Their core offerings include investment banking services, mergers and acquisitions advisory, and capital raising solutions. These services assist healthcare companies in navigating complex financial landscapes, developing innovative therapeutics and technologies, and achieving strategic growth. The firm engages with a diverse client base, including growth-stage biotechs, large-cap pharmaceuticals, healthcare service providers, and medical technology firms, focusing on markets in North America and select clients in Europe and Asia.

Leerink Partners generates revenue primarily through advisory fees from mergers and acquisitions, capital raising, and associated transactions within the healthcare sector. Their fees are based on the complexity and scale of the transaction, including a retainer fee and a success fee contingent upon completion. Their services are utilized by healthcare firms seeking to enhance operational efficiency and market presence through strategic partnerships or equity offerings. The firm's revenue is significantly driven by successful transaction completions, leveraging their specialized expertise in the healthcare investment community.

Leerink Partners is expected to continue its focus on healthcare investment banking, with plans to enhance its service offerings tailored for emerging healthcare technologies. The firm aims to expand its geographic presence in Europe and Asia by 2024. Recent funding from the Growth round will be utilized to bolster their advisory capacity and support expansion efforts. In April 2013, the company management acquired the firm, further solidifying its commitment to growth within the healthcare sector.